Skip to Navigation
University of Pittsburgh
Print This Page Print this pages

March 8, 2001

Pharmacy ranked in top 10 for NIH funding

Pitt's School of Pharmacy has been ranked in the top 10 among the nation's schools and colleges of pharmacy in National Institutes of Health (NIH) research funding. Funding from the NIH is viewed as a benchmark for a school's research programs because of the competitive and rigorous peer review process required to receive NIH funds.

Pitt's pharmacy school ranked 7th this year, jumping from 33rd in 1999, according to data compiled by the American Association of Colleges of Pharmacy.

"We are pleased that the School of Pharmacy is recognized as one of the leaders of pharmacy research," said Randy P. Juhl, dean of the school.

"To be placed in the same company as the leading schools of pharmacy is an endorsement of the excellent work being performed here," said Arthur S. Levine, senior vice chancellor for the Health Sciences.

In 1999, with support from the University, the school created the Center for Pharmacogenetics to study the interface between drug response and genetics. That development, coupled with recent strengthening of the school's research programs in drug and alcohol abuse, neuroendocrine psychopharmacology, pharmacogenetics and others, has resulted in an increase from less than $1 million to more than $4 million in NIH funding in the past year. This places the school in the top tier of the nation's research-intensive schools of pharmacy and provides a valuable and complementary resource to the school's professional education and clinical care programs.

"This growth and new level of achievement is the result of effort on the part of a very dedicated group of faculty and staff," said Patricia D. Kroboth, chair of pharmaceutical sciences.

Leave a Reply